Moreover, ACSL4 was found to be more expressed in estrogen receptor (ER)-negative cancers, such as quadruple negative breast cancer (QNBC), than that in ER-positive cancers (Yen et al., 2017). This evidence concerns the gene ESR1 and cancer.